Zhehua Zhang

Mr. Zhehua Zhang

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang Uni-versity School of Medicine

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2015 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
ZZZhehua Zhang
Zhehua Zhang
CLChanghui Liu
Changhui Liu
JBJunhui Bai
Junhui Bai
CWCuichen Wu
Cuichen Wu
YXYue Xiao
Yue Xiao
WTWeihong Tan
Weihong Tan

1 March 2017 in Journal of Chromatography A
Verified
Journal Article
Closed access
YZYun Zhang
Yun Zhang
HZHua Zhou
Hua Zhou
ZZZhehua Zhang
Zhehua Zhang
XWXiang-Lun Wu
Xiang-Lun Wu
WCWei-Guo Chen
Wei-Guo Chen
Yong-Gang ZhaoYong-Gang Zhao
Yong-Gang Zhao

4 October 2021 in Frontiers in Medicine
Verified
Journal Article
Open access
ZSZeyu Sun
Zeyu Sun
CHChenjie Huang
Chenjie Huang
YSYixian Shi
Yixian Shi
RWRusha Wang
Rusha Wang
JFJun Fan
Jun Fan
ZYZhenggang Yang
Zhenggang Yang
Hepatitis B virus (HBV) can hijack the host bile acids (BAs) metabolic pathway during infection in cell and animal models. Additionally, microbiome was known to play critical role in the enterohepatic cycle of BAs. However, the impact of HBV infection and associated gut microbiota on the BA metabolism in chronic hepatitis B (CHB) patients is unknown. This study aimed to unveil the distinct BA profiles in chronic HBV infection (CHB) patients with no or mild hepatic injury, and to explore the relationship between HBV, microbiome and BA metabolism with clinical implications.Methods: Serum BA profiles were compared between CHB patients with normal ALT (CHB-NALT, n = 92), with abnormal ALT (CHB-AALT, n = 34) and healthy controls (HCs, n = 28) using UPLC-MS measurement. Hepatic gene expression in CHB patients were explored using previously published transcriptomic data. Fecal microbiome was compared between 30 CHB-NALT and 30 HCs using 16S rRNA sequencing, and key microbial function was predicted by PICRUSt analysis.Results: Significant higher percentage of conjugated BAs and primary BAs was found in CHB patients even without apparent liver injury. Combinatory BA features can discriminate CHB patients and HCs with high accuracy (AUC = 0.838). Up-regulation of BA importer Na+ taurocholate co-transporting peptide (NTCP) and down-regulation of bile salt export pump (BSEP) was found in CHB-NALT patients. The microbial diversity and abundance of Lactobacillus, Clostridium, Bifidobacterium were lower in CHB-NALT patients compared to healthy controls. Suppressed microbial bile salt hydrolases (BSH), 7-alpha-hydroxysteroid dehydrogenase (hdhA) and 3-dehydro-bile acid Delta 4, 6-reductase (BaiN) activity were found in CHB-NALT patients.Conclusion: This study provides new insight into the BA metabolism influenced both by HBV infection and associated gut microbiome modulations, and may lead to novel strategy for clinical management for chronic HBV infection.

22 March 2019 in Analytical Chemistry
Verified
Journal Article
Closed access
DCDeying Chen
Deying Chen
JYJiong Yu
Jiong Yu
ZZZhehua Zhang
Zhehua Zhang
XSXiaoling Su
Xiaoling Su
LLLiang Li
Liang Li
LLLanjuan Li
Lanjuan Li